Dividends Calendar Earnings Calendar

BXRX | Baudax Bio

Baudax Bio
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Malvern, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 7.67M
  • Prev closed: 3.48
  • Open: 3.51
  • High: 3.61
  • Low: 3.39
  • 52 week low: 2.16
  • 52 week high: 10.14
  • Dividends:No Dividends

Next ER: March 22, 2022 



Top Stories (BXRX)

    Company Profile

    Baudax Bio is a pharmaceutical company focused on developing and commercializing innovative products for patients in acute care settings. We are committed to bringing clinically meaningful therapeutic options to patients, health care providers, and payers, such as ANJESO® (meloxicam) injection, which was approved by the U.S. Food and Drug Administration (FDA) in February 2020. ANJESO is indicated for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Because of delayed onset of analgesia, ANJESO alone is not recommended for use when rapid onset of analgesia is required. We believe we can create value for healthcare providers, patients and shareholders through our portfolio of products, which also includes a robust pipeline of product candidates. In addition, we continue to evaluate acquisition and licensing opportunities which align with our core acute care focus.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 13, 2022
    March 16, 2022-4.41 / -5.25400K / 625K
    November 4, 2021-0.2 / -0.155281K / 700K
    August 5, 2021-0.21 / -0.2201K / 633.33K
    May 5, 2021-0.27 / -0.1933198K / 500K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Mar 21, 2022 1.9900 1.8900
    2.0500
    1.8701
    565.19K 5.85%
    Mar 18, 2022 1.8800 1.8300
    1.9400
    1.8000
    343.94K 2.17%
    Mar 17, 2022 1.8400 1.7500
    1.8800
    1.7100
    363.15K 5.75%
    Mar 16, 2022 1.7400 1.6700
    1.7650
    1.6100
    387.57K 7.41%
    Mar 15, 2022 1.6200 1.6300
    1.6700
    1.5600
    362.33K 1.25%
    Mar 14, 2022 1.6000 1.6800
    1.7300
    1.5500
    364.38K -2.44%
    Mar 11, 2022 1.6400 1.7600
    1.8000
    1.6000
    420.31K -8.89%
    Mar 10, 2022 1.8000 1.8400
    1.8400
    1.6993
    345.16K -3.23%
    Mar 9, 2022 1.8600 1.6900
    2.0800
    1.6500
    2.66M 14.81%
    Mar 8, 2022 1.6200 1.6000
    1.6399
    1.4900
    859.89K 2.53%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2015
    • Employees:24

    News

    News for (BXRX)

    This company doesn't provide a dividend.


    Talk about Baudax Bio below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Mar 22, 2022 (Same day)

    adbe info ccl hqy ortx xp cuk ensv blct ogen posh pays 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.